Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes. Founded in 2018, Ansa Biotechnologies is backed by investors that include Horizons Ventures, Mubadala Capital | Ventures US, Fifty Years, and Humboldt Fund and is headquartered in Berkeley.